ストックスクリーナーアプリを入手
7.44
5.68%
0.40
アフターアワーズ：
7.42
-0.02
-0.27%
前日終値:
$7.04
開ける：
$7.07
24時間の取引高:
3.61M
Relative Volume:
2.36
時価総額：
$762.09M
収益：
$187.64M
当期純損益:
$-95.00M
株価収益率:
-7.8316
EPS:
-0.95
ネットキャッシュフロー:
$-69.02M
1週間 パフォーマンス:
-0.67%
1か月 パフォーマンス:
+5.53%
6か月 パフォーマンス:
-4.37%
1年 パフォーマンス:
-49.46%
1日の値動き範囲:
$6.97
$7.53
1週間の範囲:
$6.90
$7.86
52週間の値動き範囲:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
名前
Day One Biopharmaceuticals Inc
セクター
電話
650 484-0899
住所
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
DAWN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.44 | 721.12M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2024-10-09 | 繰り返されました | Needham | Buy |
| 2024-08-01 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-04-24 | 繰り返されました | Needham | Buy |
| 2023-04-25 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-08 | 開始されました | CapitalOne | Overweight |
| 2023-02-03 | 開始されました | Oppenheimer | Perform |
| 2022-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-14 | 開始されました | Needham | Buy |
| 2022-12-05 | 開始されました | Goldman | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
すべてを表示
Day One Biopharmaceuticals Inc (DAWN) 最新ニュース
Will Day One Biopharmaceuticals Inc. price bounce be sustainableJobs Report & Momentum Based Trading Signals - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Will Day One Biopharmaceuticals Inc. stock remain a Wall Street favoritePortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
Y Intercept Hong Kong Ltd Invests $1.83 Million in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Pattern recognition hints at Day One Biopharmaceuticals Inc. upsideTrade Analysis Report & Weekly Momentum Picks - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Day One Biopharmaceuticals Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Day One Biopharmaceuticals (NASDAQ:DAWN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Day One Biopharmaceuticals Inc. stock outlook for YEARJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
How Day One Biopharmaceuticals Inc. stock benefits from global expansionPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
Why Day One Biopharmaceuticals Inc. stock attracts global investors2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options data2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Market reaction to Day One Biopharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Multi factor analysis applied to Day One Biopharmaceuticals Inc.2025 Big Picture & Safe Entry Momentum Tips - newser.com
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - sharewise.com
Day One Biopharmaceuticals Advances Cancer Treatment with DAY301 Study - MSN
Can Day One Biopharmaceuticals Inc. rally from current levels2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Day One Biopharmaceuticals Advances Pediatric Cancer Study with Promising Drug Tovorafenib - The Globe and Mail
Day One Biopharmaceuticals (NASDAQ:DAWN) Is In A Strong Position To Grow Its Business - Yahoo Finance
Day One Biopharmaceuticals Inc (DAWN) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):